MCRB
Seres Therapeutics Inc
4.00$
-2.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Seres Therapeutics Inc (MCRB) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/05/2026 | Current report (8-K) | Seres Therapeutics, Inc. (MCRB): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 08/04/2026 | Current report (8-K) | Seres Therapeutics, Inc. (MCRB): Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 08/04/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 07/08/2026 | Current report (8-K) | Seres Therapeutics, Inc. (MCRB): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 07/08/2026 | Current report (8-K) | Seres Therapeutics, Inc. (MCRB): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.